AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 104 filers reported holding AKERO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $696,332 | -39.8% | 18,200 | -13.7% | 0.00% | -33.3% |
| Q4 2022 | $1,156,280 | +450.6% | 21,100 | -5.0% | 0.00% | +200.0% |
| Q2 2022 | $210,000 | -39.8% | 22,200 | -9.8% | 0.00% | 0.0% |
| Q1 2022 | $349,000 | -57.7% | 24,600 | -36.9% | 0.00% | -50.0% |
| Q4 2021 | $825,000 | -54.1% | 39,000 | -51.5% | 0.00% | -60.0% |
| Q3 2021 | $1,797,000 | -48.4% | 80,400 | -42.7% | 0.01% | -44.4% |
| Q2 2021 | $3,481,000 | -29.3% | 140,300 | -17.3% | 0.01% | -35.7% |
| Q1 2021 | $4,923,000 | +42.6% | 169,700 | +26.8% | 0.01% | +55.6% |
| Q4 2020 | $3,452,000 | +843.2% | 133,800 | +1024.4% | 0.01% | +800.0% |
| Q3 2020 | $366,000 | – | 11,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |